Evidence map›Paper›PMID 25155007›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2014

A critical role of the transcription factor fli-1 in murine lupus development by regulation of interleukin-6 expression.

Shuzo Sato, Mara Lennard Richard, Danielle Brandon, Joy N Jones Buie, Jim C Oates, Gary S Gilkeson, Xian K Zhang

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Pericytes mediate neuroinflammation via Fli-1 in endotoxemia and sepsis in mice.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Potential Therapeutic Value of the STING Inhibitors.Molecules (Basel, Switzerland) · 2023
    Review
  10. Article
  11. A Non-Coding Variant inFrontiers in lupus · 2023
    Article
  12. Article
  13. Article
  14. Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Fli-1 Governs Pericyte Dysfunction in a Murine Model of Sepsis.The Journal of infectious diseases · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shuzo SatoMedical University of South Carolina, Charleston.
Mara Lennard Richard
Danielle Brandon
Joy N Jones Buie
Jim C Oates
Gary S Gilkeson
Xian K Zhang
Medical University of South Carolina · USRalph H. Johnson VA Medical Center · US

Funding

Molecular mechanisms of the impact of Fli-1 on lupusR01AR056670 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ZHANG, XIAN · 2010 to 2014
$1.4M
NIAMS NIH HHS AR-056670NIAMS NIH HHS R01 AR056670
6 · The paper itself

Abstract

objectiveThe Fli-1 transcription factor is implicated in the pathogenesis of systemic lupus erythematosus (SLE), both in humans and in animal models. Dysregulation of interleukin-6 (IL-6) is also associated with SLE. The purpose of this study was to investigate whether Fli-1 directly regulates the expression of IL-6.

methodsSera were collected from wild-type and Fli-1-heterozygous (Fli-1(+/-) ) MRL/lpr mice, and the concentration of IL-6 was measured by enzyme-linked immunosorbent assay (ELISA). Expression of IL-6 in the kidney was measured by real-time polymerase chain reaction analysis. T cells were isolated from wild-type and Fli-1(+/-) MRL/lpr mice and stimulated with CD3/CD28 beads, and the concentration of IL-6 in the supernatants was measured by ELISA. MS1 endothelial cells were transfected with Fli-1 and control small interfering RNA, and the production of IL-6 was compared after lipopolysaccharide stimulation. A chromatin immunoprecipitation (ChIP) assay was performed to determine whether Fli-1 binds to the IL-6 promoter region. Transient transfections with the NIH3T3 cell line were performed to examine whether Fli-1 regulates the expression of IL-6.

resultsFli-1(+/-) MRL/lpr mice had significantly decreased IL-6 levels in sera and reduced expression of IL-6 in kidneys as compared to their wild-type littermates. T cells isolated from Fli-1(+/-) MRL/lpr mice produced less IL-6 than did those from wild-type mice. Inhibiting the expression of Fli-1 in endothelial cells resulted in reduced production of IL-6. The ChIP assay revealed direct binding of Fli-1 to 3 regions within the IL-6 promoter. Fli-1 activated transcription from the IL-6 promoter in a dose-dependent manner.

conclusionThe direct regulation of IL-6 expression by Fli-1 represents one possible mechanism for the protective effect of decreased Fli-1 expression in lupus.

Indexed as

Gene Expression RegulationAnimalsAutoantibodiesChromatin ImmunoprecipitationDisease Models, AnimalEnzyme-Linked Immunosorbent AssayHeterozygoteInterleukin-6KidneyLipopolysaccharidesLupus Erythematosus, SystemicMiceMice, Inbred MRL lprNIH 3T3 CellsPromoter Regions, GeneticProto-Oncogene Protein c-fli-1AutoantibodiesFli1 protein, mouseInterleukin-6LipopolysaccharidesProto-Oncogene Protein c-fli-1RNA, Messenger

Identifiers

PMID25155007
PMCPMC4245454
OpenAlexW1920768258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.